{
     "PMID": "26440732",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20160815",
     "LR": "20170807",
     "IS": "1558-1497 (Electronic) 0197-4580 (Linking)",
     "VI": "36",
     "IP": "12",
     "DP": "2015 Dec",
     "TI": "A truncating mutation in Alzheimer's disease inactivates neuroligin-1 synaptic function.",
     "PG": "3171-3175",
     "LID": "S0197-4580(15)00450-9 [pii] 10.1016/j.neurobiolaging.2015.09.004 [doi]",
     "AB": "Neuroligins (NLs) are cell-adhesion proteins that regulate synapse formation and function. Neuroligin 1 (NL1) promotes the formation of glutamatergic synapses and mediates long-term potentiation in mouse models. Thus, altered NL1 function could mediate the synaptic and memory deficits associated with Alzheimer's disease (AD). Here, we describe a frameshift mutation, c.875_876insTT, in the neuroligin 1 gene (NLGN1) in a patient with AD and familial history of AD. The insertion generates a premature stop codon in the extracellular domain of NL1 (p.Thr271fs). Expression of mutant NL1 shows accumulation of truncated NL1 proteins in the endoplasmic reticulum. In hippocampal neurons, the p.Thr271fs mutation abolishes the ability of NL1 to promote the formation of glutamatergic synapses. Our data support a role for inactivating mutations in NLGN1 in AD. Previous studies have reported rare mutations in X-linked NLGNL3 and NLGNL4 genes in patients with autism, which result in the inactivation of the mutant alleles. Therefore, together with a role in neurodevelopmental disorders, altered NL function could underlie the molecular mechanisms associated with brain diseases in the elderly.",
     "CI": [
          "Copyright (c) 2015 Elsevier Inc. All rights reserved."
     ],
     "FAU": [
          "Tristan-Clavijo, Enriqueta",
          "Camacho-Garcia, Rafael J",
          "Robles-Lanuza, Estefania",
          "Ruiz, Agustin",
          "van der Zee, Julie",
          "Van Broeckhoven, Christine",
          "Hernandez, Isabel",
          "Martinez-Mir, Amalia",
          "Scholl, Francisco G"
     ],
     "AU": [
          "Tristan-Clavijo E",
          "Camacho-Garcia RJ",
          "Robles-Lanuza E",
          "Ruiz A",
          "van der Zee J",
          "Van Broeckhoven C",
          "Hernandez I",
          "Martinez-Mir A",
          "Scholl FG"
     ],
     "AD": "Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Sevilla, Spain; Departamento de Fisiologia Medica y Biofisica, Facultad de Medicina, Universidad de Sevilla, Sevilla, Spain. Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Sevilla, Spain. Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Sevilla, Spain; Departamento de Fisiologia Medica y Biofisica, Facultad de Medicina, Universidad de Sevilla, Sevilla, Spain. Research Center and Memory Clinic, Fundacio ACE, Institut Catala de Neurociencies Aplicades, Barcelona, Spain. Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, VIB, Antwerp, Belgium; Laboratory of Neurogenetics, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium. Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, VIB, Antwerp, Belgium; Laboratory of Neurogenetics, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium. Research Center and Memory Clinic, Fundacio ACE, Institut Catala de Neurociencies Aplicades, Barcelona, Spain. Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Sevilla, Spain. Electronic address: amm-ibis@us.es. Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Sevilla, Spain; Departamento de Fisiologia Medica y Biofisica, Facultad de Medicina, Universidad de Sevilla, Sevilla, Spain. Electronic address: fgs@us.es.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20150910",
     "PL": "United States",
     "TA": "Neurobiol Aging",
     "JT": "Neurobiology of aging",
     "JID": "8100437",
     "RN": [
          "0 (Cell Adhesion Molecules, Neuronal)",
          "0 (Codon, Terminator)",
          "0 (neuroligin 1)"
     ],
     "SB": "IM",
     "MH": [
          "Aged",
          "Alzheimer Disease/*genetics/psychology",
          "Animals",
          "COS Cells",
          "Cell Adhesion Molecules, Neuronal/metabolism/*physiology",
          "Cercopithecus aethiops",
          "Codon, Terminator/genetics",
          "Endoplasmic Reticulum/metabolism",
          "Female",
          "*Frameshift Mutation",
          "Gene Silencing/*physiology",
          "Hippocampus/cytology",
          "Humans",
          "Long-Term Potentiation/genetics",
          "Memory",
          "Rats",
          "Synapses/*genetics/*physiology"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Alzheimer's disease",
          "Mutation",
          "NLGN1",
          "Neuroligin",
          "Synapse"
     ],
     "EDAT": "2015/10/07 06:00",
     "MHDA": "2016/08/16 06:00",
     "CRDT": [
          "2015/10/07 06:00"
     ],
     "PHST": [
          "2015/06/26 00:00 [received]",
          "2015/09/02 00:00 [revised]",
          "2015/09/03 00:00 [accepted]",
          "2015/10/07 06:00 [entrez]",
          "2015/10/07 06:00 [pubmed]",
          "2016/08/16 06:00 [medline]"
     ],
     "AID": [
          "S0197-4580(15)00450-9 [pii]",
          "10.1016/j.neurobiolaging.2015.09.004 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Neurobiol Aging. 2015 Dec;36(12):3171-3175. doi: 10.1016/j.neurobiolaging.2015.09.004. Epub 2015 Sep 10.",
     "term": "hippocampus"
}